My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
March 2016
IDSA Comments on NSABB Draft Recommendations on Gain-of-Function Research
IDSA recently submitted comments on draft recommendations from the federal agency that is charged with developing a flexible, transparent regulatory framework to oversee so-called “gain-of-function” (GOF) research of concern on pathogens with pandemic potential. 
In late 2014, the White House Office of Science and Technology Policy issued a “pause” for all gain-of-function research, defined as “that which aims to increase the transmissibility, host-range, and/or pathogenicity of a pathogen,” so that the risks and benefits associated with such research can be more effectively assessed. The White House directed the National Science Advisory Board for Biosecurity (NSABB) to establish a framework by which this risk/benefit assessment can be undertaken. The NSABB undertook a risk benefit assessment of the paused research in the summer of 2015 to inform the development of its recommendations.  
At the time, IDSA submitted recommendations to the NSABB and followed up with a Journal of Infectious Diseases editorial.  
In its new comment letter, IDSA applauded the NSABB’s efforts to address IDSA’s earlier recommendations, including NSABB’s focus back to only the research of highest concern and its exclusion of seasonal influenza vaccine manufacturing and development. On the other hand, IDSA expressed concern that the NSABB’s latest recommendations will not provide the appropriate guidance needed to develop a streamlined mechanism that provides appropriate oversight of the risk and benefits of GOF research of concern.
Final recommendations are expected to be released by NSABB in May.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Infections Associated with Heater-Cooler Devices
HCV Guidance Website Updated to Reflect Latest Drug Developments
HIVMA Joins Leading Health and Healthcare Organizations in Choosing Wisely® Campaign
What’s Facing ID Specialists in the Health Care Payment Reform Landscape?
Deadline Extended to Avoid 2017 Medicare EHR Incentive Program Payment Penalties
Changes to CMS Sepsis Quality Measure Based on IDSA Input
Hepatitis C Treatment Access Resources for Providers
IDSA, HIVMA Join in Development of Core Quality Measures
Take 3 Minutes to Support Legislative Proposal to Appropriately Value ID Services
IDSA Supports Senate Committee Effort to Address CRE Outbreaks from Duodenoscopes
IDSA Comments on NSABB Draft Recommendations on Gain-of-Function Research
Science Speaks
ABIM Updates
Free Hepatitis C Module and Other MOC Resources
Apply Now for IDSA Fellow Advancement
Nominate Your Colleague for an IDSA or HIVMA Award
Member Report
Zika: Working Together as Specialists and a Society to End an Outbreak
What Comes to Mind When You Hear of New Orleans in October? Think IDWeek!
Call for Committee Volunteers!
President’s Budget Request for FY 2017 is Out: What it Holds for ID and HIV
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.